Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (191-200 of 392) with videos related to

Pageof 40
Sort By:
International Journal of Antimicrobial Agents|July 11, 2017
Shortening the incubation time for the combination disk diffusion extended-spectrum β-lactamase (ESBL) confirmation test: how far can we go?Wouter van den Bijllaardt, Patricia C M Voermans, Anton G Buiting, et al.
Clinical Pharmacology and Therapeutics|May 16, 2002
Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoringMatthijs de Hoog, Johan W Mouton, Rik C Schoemaker, et al.
Journal of Microbiological Methods|February 9, 2020
Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapyIain J Abbott, Elke van Gorp, Rixt A Wijma, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2013
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serumAntigoni Elefanti, Johan W Mouton, Katerina Krompa, et al.
Journal of Clinical Microbiology|August 30, 2001
Colorimetric assay for antifungal susceptibility testing of Aspergillus speciesJ Meletiadis, J W Mouton, J F Meis, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Protein binding: do we ever learn?Markus A Zeitlinger, Hartmut Derendorf, Johan W Mouton, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 6, 2015
Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infectionsM H T Stappers, F Hagen, P Reimnitz, et al.
Journal of Clinical Microbiology|January 13, 2004
Amplified fragment length polymorphism fingerprinting is an effective technique to distinguish streptococcus pneumoniae from other Streptococci and an efficient alternative to pulsed-field gel electrophoresis for molecular typing of pneumococciChris Neeleman, Corné H W Klaassen, Hanneke A de Valk, et al.
The Lancet. Infectious Diseases|April 27, 2018
Colistin versus colistin plus meropenem for severe infections Authors' replyMical Paul, Yehuda Carmeli, George L Daikos, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infectionIrma A J M Bakker-Woudenberg, Marian T ten Kate, Wil H F Goessens, et al.
Pageof 40

Showing results (191-200 of 392) with videos related to

Sort By:
Pageof 40
International Journal of Antimicrobial Agents|July 11, 2017
Shortening the incubation time for the combination disk diffusion extended-spectrum β-lactamase (ESBL) confirmation test: how far can we go?Wouter van den Bijllaardt, Patricia C M Voermans, Anton G Buiting, et al.
Clinical Pharmacology and Therapeutics|May 16, 2002
Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoringMatthijs de Hoog, Johan W Mouton, Rik C Schoemaker, et al.
Journal of Microbiological Methods|February 9, 2020
Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapyIain J Abbott, Elke van Gorp, Rixt A Wijma, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2013
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serumAntigoni Elefanti, Johan W Mouton, Katerina Krompa, et al.
Journal of Clinical Microbiology|August 30, 2001
Colorimetric assay for antifungal susceptibility testing of Aspergillus speciesJ Meletiadis, J W Mouton, J F Meis, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Protein binding: do we ever learn?Markus A Zeitlinger, Hartmut Derendorf, Johan W Mouton, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 6, 2015
Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infectionsM H T Stappers, F Hagen, P Reimnitz, et al.
Journal of Clinical Microbiology|January 13, 2004
Amplified fragment length polymorphism fingerprinting is an effective technique to distinguish streptococcus pneumoniae from other Streptococci and an efficient alternative to pulsed-field gel electrophoresis for molecular typing of pneumococciChris Neeleman, Corné H W Klaassen, Hanneke A de Valk, et al.
The Lancet. Infectious Diseases|April 27, 2018
Colistin versus colistin plus meropenem for severe infections Authors' replyMical Paul, Yehuda Carmeli, George L Daikos, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infectionIrma A J M Bakker-Woudenberg, Marian T ten Kate, Wil H F Goessens, et al.
Pageof 40